-
1Academic Journal
المؤلفون: Yildirim, M.E., Cil, T., Artac, M., Hacibekiroglu, I., Sumbul, A.T., Uncu, D., Ozturk, A., Isikdogan, A., Sezgin Goksu, S., Ates, O., Karadurmus, N., Sendur, M.A.N., Koral, L., Bilici, M., Demirci, U., Geredeli, C., Arslan, C., Türk, H.M., Cicin, I., Gumus, M.
المصدر: ESMO Open ; volume 9, page 102625 ; ISSN 2059-7029
-
2Academic Journal
المؤلفون: Gumus, M., Sukalinskaya, A., Andric, Z.G., Cheshuk, V., Ciuleanu, T-E., Sezgin Goksu, S., Cil, T., Cicin, I., Bulat, I.V., Ostapenko, Y.V., Penkov, K.D., Hart, C., Lai, M., Chaao, B., Jimenez, J., Sepahi, A., Shi, G., Trott, S., Hooper, E.
المصدر: Immuno-Oncology and Technology ; volume 16, page 100293 ; ISSN 2590-0188
-
3Academic Journal
المؤلفون: Artac, M., Cağlayan, D., Koçak, M.Z., Geredeli, C., Tatli, A.M., Sezgin Goksu, S., Karakurt Ery lmaz, M., Araz, M.
المصدر: Annals of Oncology ; volume 33, page S644-S645 ; ISSN 0923-7534
-
4Academic Journal
المؤلفون: Senan, S.1 (AUTHOR), Spigel, D.R.2 (AUTHOR), Cho, B.C.3 (AUTHOR), Laktionov, K.4 (AUTHOR), Zenke, Y.5 (AUTHOR), Lee, K.H.6 (AUTHOR), Wang, Q.7 (AUTHOR), Navarro Mendivil, A.F.8 (AUTHOR), Buchmeier, E.L.9 (AUTHOR), Sezgin Goksu, S.10 (AUTHOR), Badzio, A.11 (AUTHOR), Shi, A.12 (AUTHOR), Daniel, D.B.13 (AUTHOR), Zemanova, M.14 (AUTHOR), Iyengar, P.15 (AUTHOR), Paz-Ares, L.G.16 (AUTHOR), Szadkowski, L.17 (AUTHOR), Chugh, P.18 (AUTHOR), Lai, W.C.V.19 (AUTHOR), Cheng, Y.20 (AUTHOR)
المصدر: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1267-S1268. 2p.
مصطلحات موضوعية: *CHEMORADIOTHERAPY, *IRRADIATION
-
5Academic Journal
المؤلفون: Lim, Elgene, Boyle, Frances, Okera, Meena, Sezgin Goksu, Sema, van Hal, Gertjan, Bellet Ezquerra, Meritxell, Loi, Sherene
المساهمون: Institut Català de la Salut, Lim E Garvan Institute of Medical Research, St. Vincent’s Clinical School, University of New South Wales, Darlinghurst, NSW, Australia. Boyle F Mater Hospital, North Sydney, NSW, Australia. Okera M Adelaide Cancer Centre, Kurralta Park, SA, Australia. Loi S Peter MacCallum Cancer Centre, Melbourne, VI, Australia. Sezgin Goksu S Akdeniz University Medical Faculty, Antalya, Turkey. van Hal G Eli Lilly and Company, Utrecht, Netherlands. Bellet Ezquerra M Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: Mama - Càncer - Tractament, Diarrea, Medicaments antineoplàstics - Efectes secundaris, DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, DISEASES::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Signs and Symptoms, Digestive::Diarrhea, Other subheadings::Other subheadings::Other subheadings::/chemically induced, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mama, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, ENFERMEDADES::afecciones patológicas, signos y síntomas::signos y síntomas::signos y síntomas digestivos::diarrea, Otros calificadores::Otros calificadores::Otros calificadores::/inducido químicamente
وصف الملف: application/pdf
Relation: Breast Cancer Research and Treatment;195; https://doi.org/10.1007/s10549-022-06690-5; Lim E, Boyle F, Okera M, Loi S, Sezgin Goksu S, van Hal G, et al. An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer. Breast Cancer Res Treat. 2022 Oct;195:275–87.; https://hdl.handle.net/11351/8291; 000834706600001
-
6
المؤلفون: Elgene Lim, Frances Boyle, Meena Okera, Sherene Loi, Sema Sezgin Goksu, Gertjan van Hal, Sonya C. Chapman, Jonathon Colby Gable, Yanyun Chen, Gregory L. Price, Anwar M. Hossain, M. Corona Gainford, Meritxell Bellet Ezquerra
المساهمون: Institut Català de la Salut, [Lim E] Garvan Institute of Medical Research, St. Vincent’s Clinical School, University of New South Wales, Darlinghurst, NSW, Australia. [Boyle F] Mater Hospital, North Sydney, NSW, Australia. [Okera M] Adelaide Cancer Centre, Kurralta Park, SA, Australia. [Loi S] Peter MacCallum Cancer Centre, Melbourne, VI, Australia. [Sezgin Goksu S] Akdeniz University Medical Faculty, Antalya, Turkey. [van Hal G] Eli Lilly and Company, Utrecht, Netherlands. [Bellet Ezquerra M] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: Diarrhea, Cancer Research, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Signs and Symptoms, Digestive::Diarrhea [DISEASES], afecciones patológicas, signos y síntomas::signos y síntomas::signos y síntomas digestivos::diarrea [ENFERMEDADES], Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], Otros calificadores::Otros calificadores::/inducido químicamente [Otros calificadores], Aminopyridines, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Breast Neoplasms, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Loperamide, Medicaments antineoplàstics - Efectes secundaris, Oncology, Antineoplastic Combined Chemotherapy Protocols, Mama - Càncer - Tractament, Other subheadings::Other subheadings::/chemically induced [Other subheadings], Humans, Benzimidazoles, Female, Diarrea
وصف الملف: application/pdf